Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms
- PMID: 16040622
- DOI: 10.1093/jac/dki269
Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms
Abstract
Objectives: Candidiasis can be associated with the formation of biofilms on bioprosthetic surfaces and the intrinsic resistance of Candida albicans biofilms to the most commonly used antifungal agents has been demonstrated. In this study, we report on the antifungal activity of caspofungin at two different concentrations, on C. albicans and Candida parapsilosis biofilms with different ages of maturation.
Methods: Fifteen strains of C. albicans (10 strains susceptible to fluconazole in vitro and five strains resistant to this antifungal agent) and six strains of C. parapsilosis (all were susceptible to fluconazole in vitro) were studied. The antifungal activity of caspofungin was assessed by looking for a significant inhibition of the metabolic activity of yeasts within biofilms. Biofilms of Candida were produced in vitro, on silicone catheters.
Results: Caspofungin used at MIC did not modify the metabolic activity of C. albicans, whatever the maturation age of the biofilms. The same concentration of caspofungin significantly reduced the metabolism (P<or=0.001) of 25% (biofilms of 48 h) to 50% (biofilms of 2 h) of the C. parapsilosis yeasts. The use of a therapeutic concentration of caspofungin (2 mg/L) significantly decreased (P<or=0.001) the metabolism of all the strains of C. albicans and C. parapsilosis tested, independently of the biofilm maturation age. This potent antifungal activity of caspofungin on C. albicans biofilms was observed independently of the yeast susceptibility to fluconazole.
Conclusions: This study demonstrated that caspofungin used at MIC was not sufficient to reduce C. albicans biofilms, but it suggested an activity on C. parapsilosis biofilms depending on their maturation age. This study also indicated that caspofungin used at 2 mg/L could be a good candidate in the prevention of candidiasis associated with silicone medical devices. Our results also suggested that fluconazole resistance of yeasts did not affect caspofungin activity.
Similar articles
-
Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins.J Antimicrob Chemother. 2004 Mar;53(3):522-5. doi: 10.1093/jac/dkh099. Epub 2004 Jan 28. J Antimicrob Chemother. 2004. PMID: 14749343
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.Virulence. 2015;6(4):385-94. doi: 10.1080/21505594.2015.1027479. Virulence. 2015. PMID: 26065323 Free PMC article.
-
In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.J Antimicrob Chemother. 2008 Jul;62(1):153-5. doi: 10.1093/jac/dkn160. Epub 2008 Apr 10. J Antimicrob Chemother. 2008. PMID: 18407917
-
Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.Braz J Microbiol. 2022 Sep;53(3):1101-1113. doi: 10.1007/s42770-022-00739-9. Epub 2022 Mar 29. Braz J Microbiol. 2022. PMID: 35352319 Free PMC article. Review.
Cited by
-
What Could Be the Role of Antifungal Lock-Solutions? From Bench to Bedside.Pathogens. 2018 Jan 6;7(1):6. doi: 10.3390/pathogens7010006. Pathogens. 2018. PMID: 29316615 Free PMC article. Review.
-
In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.Antimicrob Agents Chemother. 2015 Dec;59(12):7611-20. doi: 10.1128/AAC.01890-15. Epub 2015 Sep 28. Antimicrob Agents Chemother. 2015. PMID: 26416861 Free PMC article.
-
Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.Antimicrob Agents Chemother. 2008 Jan;52(1):357-60. doi: 10.1128/AAC.00856-07. Epub 2007 Oct 15. Antimicrob Agents Chemother. 2008. PMID: 17938192 Free PMC article.
-
CaIPF19998 reduces drug susceptibility by enhancing the ability of biofilm formation and regulating redox homeostasis in Candida albicans.Curr Microbiol. 2013 Sep;67(3):322-6. doi: 10.1007/s00284-013-0366-x. Epub 2013 Apr 26. Curr Microbiol. 2013. PMID: 23620174
-
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.Eur J Med Res. 2011 Apr 28;16(4):159-66. doi: 10.1186/2047-783x-16-4-159. Eur J Med Res. 2011. PMID: 21486730 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources